Jennifer Berres Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 3 weeks ago
Jennifer Berres has an estimated net worth of at least $11.9 million*, as of Oct. 29, 2025. They own 11,993 shares of HCA stock. They have sold 23,911 shares of HCA stock since 2021, for an estimated $4.6 million.
Jennifer Berres $HCA SEC Form 4 Insider Trading
Jennifer Berres has filed a total of 6 insider trades in $HCA since 2021. Their most recent trade was a sale of 4,010 shares, made on Feb 11, 2026. Their largest trade was a sale of 5,378 shares, made on Feb 14, 2025. We estimate that they now own 11,993 shares of $HCA, worth an estimated $7.2 million.
Insider Trading at $HCA
There have been a total of 143 insider trades reported at $HCA since 2021, with 95,131 shares purchased and 582,468 shares sold. The most active insider traders in $HCA stock have been Samuel N Hazen, Kathryn A. Torres, and Kathleen M Whalen. The most recent trade was a sale of 1,694 shares reported by Michael R McAlevey (EVP & Chief Legal & Admin Off.), made on Feb 18, 2026.
History of Insider Stock Trades by Jennifer Berres
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
HCA
|
Sale | 4,010 | Feb 11, 2026 | Feb. 12, 2026, 7:36 p.m. |
HCA
|
Sale | 4,010 | Feb 11, 2026 | Feb. 12, 2026, 7:36 p.m. |
HCA
|
Sale | 4,155 | Feb 14, 2025 | Feb. 18, 2025, 8:28 p.m. |
HCA
|
Sale | 5,378 | Feb 14, 2025 | Feb. 18, 2025, 8:28 p.m. |
HCA
|
Sale | 4,000 | Feb 07, 2023 | Feb. 9, 2023, 7:15 p.m. |
HCA
|
Sale | 2,358 | May 13, 2022 | May 17, 2022, 5:40 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Samuel N Hazen, CEO
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Charles J Hall, Group President
-
Christopher F. Wyatt, SVP & Controller
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Bill B Rutherford, CFO and EVP
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
Phillip G Billington, SVP-Internal Audit Services
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jon M Foster, EVP and COO
-
Michael R Mcalevey, EVP & Chief Legal & Admin Off.
-
Jeffrey E. Cohen, SVP-Government Relations
-
Timothy M Mcmanus, Group President
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.